Speakers: April W. Armstrong, MD, MPH, FAAD and Eingun James Song, MD, FAAD

Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY

Please join us for our next IDF Educational Series Webinar: Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies. This educational webinar will provide an overview of moderate-to-severe atopic dermatitis as a chronic, relapsing inflammatory disease driven by underlying type 2 immune dysregulation and skin barrier dysfunction. April W. Armstrong, MD, MPH, FAAD will review the clinical presentation, disease burden, and impact on patients’ quality of life, including pruritus, sleep disturbance, and psychosocial effects. The session will also highlight current challenges in disease management and ongoing unmet needs, offering insights to support a deeper understanding of atopic dermatitis and inform clinical decision-making. and EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients? Join your colleagues for a peer discussion exploring the latest EBGLYSS data. This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

CLICK HERE TO REGISTER